Catalyst Wire Dossier Catalyst Wire Dossier

ORLYNVAH

SULOPENEM ETZADROXIL AND PROBENECID · ITERUM THERAPEUTICS US LIMITED
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ORLYNVAH, covering 2024-10-25 to 2025-12-23. Get the full timeline:

Most recent: FDA Approved: ORLYNVAH — Supplemental Application (ITERUM THERAPEUTICS US LIMITED)

See pricing